BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim HM, Lee N, Kim MS, Kang C, Chung YS. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea. Virol J 2020;17:94. [PMID: 32631440 DOI: 10.1186/s12985-020-01375-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cáceres CJ, Hu Y, Cárdenas-García S, Wu X, Tan H, Carnaccini S, Gay LC, Geiger G, Ma C, Zhang QY, Rajao D, Perez DR, Wang J. Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with in vivo antiviral efficacy against both oseltamivir sensitive and -resistant influenza A viruses. Emerg Microbes Infect 2021;10:1832-48. [PMID: 34427541 DOI: 10.1080/22221751.2021.1972769] [Reference Citation Analysis]
2 Boonnak K, Mansanguan C, Schuerch D, Boonyuen U, Lerdsamran H, Jiamsomboon K, Sae Wang F, Huntrup A, Prasertsopon J, Kosoltanapiwat N, Puthavathana P. Molecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018-2019. Viruses 2021;13:977. [PMID: 34070388 DOI: 10.3390/v13060977] [Reference Citation Analysis]
3 Park JH, Kim B, Antigua KJC, Jeong JH, Kim CI, Choi WS, Oh S, Kim CH, Kim EG, Choi YK, Baek YH, Song MS. Baloxavir-oseltamivir combination therapy inhibits the emergence of resistant substitutions in influenza A virus PA gene in a mouse model. Antiviral Res 2021;193:105126. [PMID: 34217753 DOI: 10.1016/j.antiviral.2021.105126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zyryanov SK, Butranova OI, Gaidai DS, Kryshen KL. [Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities]. Ter Arkh 2021;93:114-24. [PMID: 33720636 DOI: 10.26442/00403660.2021.01.200551] [Reference Citation Analysis]
5 Kim Y, Lee S, Kim Y, Jang IJ, Lee S. Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects. Clin Transl Sci 2021. [PMID: 34664769 DOI: 10.1111/cts.13160] [Reference Citation Analysis]